Sriveda Boyalakuntla/LinkedIn
Jan 4, 2026, 21:39
Sriveda Boyalakuntla Takes The ASH25 Abstract Achievement Award
Sriveda Boyalakuntla, Volunteer at Mass General Hospital, shared on LinkedIn:
”Grateful for the opportunity to attend ASH25 and present our work on abbreviated DOAC therapy for pediatric infection-associated cerebral venous sinus thrombosis.
I’m honored to have received an Abstract Achievement Award for this work.
A huge thank you to Dr. Riten Kumar for the incredible mentorship and guidance throughout this project without whose support this experience would not be possible.
I learned so much from the conference, listening to experts in hematology, meeting inspiring professionals, and engaging with the hematology community.
I’m excited to carry these insights forward in my future endeavors.”

Stay updated with Hemostasis Today.
-
Aug 22, 2026, 13:07Saneha Anjum Shaikh: Blood Bank Basics and Quality Control in Automation
-
Aug 22, 2026, 11:36Bernardo Gindri: How platelets Influence Cancer Progression
-
Aug 22, 2026, 11:34Nick Gehrig: Extending Platelet Shelf Life to Strengthen Blood Supply
-
Aug 22, 2026, 11:14Lei Yu: New Guidance for Acute Pulmonary Embolism in 2026
-
Aug 22, 2026, 11:01Neeraj Songara: Shelf-Stable Synthetic Blood – The Future of Emergency Transfusion?
-
Aug 22, 2026, 10:41Mike R.։ VTE Thrombectomy – Defining What Success Really Means
-
Aug 22, 2026, 10:28Steven Meier: What Happens During PRP Therapy?
-
Aug 22, 2026, 10:05Ralf Ludwig: When a Promising Biomarker Falls Short
-
Aug 22, 2026, 09:33Mary Cushman: What Causes PE to Happen in People with DVT?